Here are five notes:
1. The analysts have an “outperform” rating on Surgery Partners’ shares.
2. RBC Capital’s price target indicates a potential upside of 25 percent from Surgery Partners’ previous close.
3. Surgery Partners has a 12-month high of $22.32 and 12-month low of $11.97.
4. The company has a market cap of $770.50 million.
5. For the fourth quarter, Surgery Partners had an EPS of $0.35.
For more on Surgery Partners’ fourth quarter results, click here.
More articles on surgery centers:
Children’s Hospital of Richmond at VCU to open outpatient pavilion: 4 notes
OhioHealth to expand outpatient services: 4 things to know
4 key points on DuPage Medical Group acquiring Midwest ENT Consultants
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
